Market Research Report - 250703
Pharmaceutical Launch Sequencing: Mapping Commercialization Opportunities to Maximize Global Value and Expand Market Access
|Published by||Cutting Edge Information|
|Published||Content info||315 Pages|
|Pharmaceutical Launch Sequencing: Mapping Commercialization Opportunities to Maximize Global Value and Expand Market Access|
|Published: September 18, 2012||Content info: 315 Pages||
Reference pricing significantly impacts today's biopharmaceutical launch strategies. Because countries increasingly reference other nations to set their own prices, an early launch in a low-price market results in lower revenue potential worldwide. To maximize product revenue, especially for innovative drugs, companies must carefully prioritize the order in which different markets receive their products.
Global launch sequencing is a complex task requiring input from stakeholders companywide, from the C-level suite to affiliate offices. Successful teams develop launch calendars to leverage internal expertise, and they strategically address country-level challenges in each launch market - preventing costly delays.
Use this report to determine the optimal product launch schedule. Data benchmarks and tables for 14 specific markets detail how top-performing companies prioritize lucrative markets while overcoming hurdles in regulatory and reimbursement processes.
Understanding reference pricing is essential in building effective global launch calendars. Learn how companies weigh this factor and nine others when setting a launch course, and benchmark individual countries' global launch positions from first-wave to fourth-wave launches.
Work with C-level executives, market access teams and other internal stakeholders to eliminate duplicated efforts and account for country-level requirements. Benchmark time spent on sequence planning and gauge companies' satisfaction with these timelines.
The emerging markets are a growth engine for pharma. Weigh potential revenue opportunities against regulatory and pricing challenges to prioritize launches in the BRIC countries, and navigate changing regulatory processes and agencies, as well as value-based pricing challenges, in key launch markets.
24 charts focused on global launch sequence planning:
Each country profile contains the same elements. Tables illustrate the country's economic, demographic, and healthcare information. Charts explore different factors influencing a country's global launch sequencing position.
7 tables and 8 charts per profile focus on various aspects influencing a company's global launch sequence: